Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erector Spinae Lumbar Block for Acute Low Back Pain (Pilot Study)
2024-511818-21-00Phase 3Authorised
- Sponsor
- Santé Atlantique
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine and dexamethasone in acute lumbago, sponsored by Santé Atlantique. Primary endpoint: Area under the curve of activity-related pain over first 4 days. Planned start Jul 2024; status: authorised.
02
Drugs
ropivacainedexamethasone
03
Conditions
acute lumbago
Beyond the preview
Go deeper on 2024-511818-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511818-21-00.